Link to this page
Physician Data Query
Last uploaded:
August 27, 2019
Jump to:
| Preferred Name | vidarabine | |
| Synonyms |
9-Beta-D-arabinofuranosyladenine Monohydrate adenine arabinoside ARA-A araadenosine Vira-A 9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate Beta Ara-A CI-673 Arabinosyladenine Spongoadenosine Arasena-A |
|
| Definitions |
A nucleoside antibiotic isolated from the bacterium Streptomyces antibioticus with antineoplastic activity. Vidarabine inhibits DNA polymerase, resulting in the inhibition of DNA replication in tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C929" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C929" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000039150 |
|
| altLabel |
9-Beta-D-arabinofuranosyladenine Monohydrate adenine arabinoside ARA-A araadenosine Vira-A 9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate Beta Ara-A CI-673 Arabinosyladenine Spongoadenosine Arasena-A
|
|
| CAS Registry |
5536-17-4
|
|
| cui |
C1519983 C0699565 C1527321 C0042646
|
|
| Date last modified |
2006-12-12
|
|
| definition |
A nucleoside antibiotic isolated from the bacterium Streptomyces antibioticus with antineoplastic activity. Vidarabine inhibits DNA polymerase, resulting in the inhibition of DNA replication in tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C929" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C929" NCI Thesaurus)
|
|
| IND Code |
18288 8593
|
|
| Legacy PDQ ID |
1770
|
|
| LT |
TRD
|
|
| NCI ID |
C929
|
|
| notation |
CDR0000039150
|
|
| NSC Code |
404241
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
vidarabine
|
|
| tui |
T114 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping